Taoyuan, Taiwan

Jian-Hua Zhao

This inventor holds 1 USPTO granted patent. Top assignee: Institute of Nuclear Energy Research. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jian-Hua Zhao. Retrieved from https://idiyas.com/inventor/jian-hua-zhao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jian-Hua Zhao

Introduction

Jian-Hua Zhao is a prominent inventor based in Taoyuan, Taiwan. He has made significant contributions to the field of medical diagnostics, particularly in relation to Alzheimer's disease. His innovative work has garnered attention for its potential impact on early diagnosis and treatment.

Latest Patents

Jian-Hua Zhao holds a patent for the use of N-(4-isopropylphenyl)-5-amino-isoindoline. This invention relates to a novel application of this compound for diagnosing Alzheimer's disease and quantifying amyloid in the brain. His patent represents a crucial step forward in the fight against this debilitating condition, offering new avenues for research and clinical application.

Career Highlights

Zhao is affiliated with the Institute of Nuclear Energy Research, Atomic Energy Council, Executive Yuan, R.O.C. His work at this esteemed institution has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Wan-I Kuo and Kang-Wei Chang. Their collaborative efforts have further advanced the research and development of innovative solutions in medical diagnostics.

Conclusion

Jian-Hua Zhao's contributions to the field of Alzheimer's disease diagnostics highlight the importance of innovation in medical research. His work not only enhances our understanding of the disease but also paves the way for future advancements in treatment and diagnosis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…